{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:24:08Z","timestamp":1760235848992,"version":"build-2065373602"},"reference-count":35,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T00:00:00Z","timestamp":1632700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["grants PI18-00164 (to F.B.-V. and M.T.), PI19-00136 (to J.C.E-G), Rio Hortega contract CM20\/00033 (to M.C)","CIBERDEM and CIBERCV"],"award-info":[{"award-number":["grants PI18-00164 (to F.B.-V. and M.T.), PI19-00136 (to J.C.E-G), Rio Hortega contract CM20\/00033 (to M.C)","CIBERDEM and CIBERCV"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2019-104367RB-100","Subprograma Ram\u00f3n y Cajal (RYC-201722879) to N.R"],"award-info":[{"award-number":["PID2019-104367RB-100","Subprograma Ram\u00f3n y Cajal (RYC-201722879) to N.R"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Impaired HDL-mediated macrophage cholesterol efflux and higher circulating concentrations of trimethylamine N-oxide (TMAO) levels are independent risk factors for cardiovascular mortality. The TMAO precursors, \u03b3-butyrobetaine (\u03b3BB) and Trimethyllysine (TML), have also been recently associated with cardiovascular death, but their interactions with HDL-mediated cholesterol efflux remain unclear. We aimed to determine the associations between APOB depleted plasma-mediated macrophage cholesterol efflux and plasma TMAO, \u03b3BB, and TML concentrations and explore their association with two-year follow-up mortality in patients with acute ST-elevation myocardial infarction (STEMI) and unstable angina (UA). Baseline and ATP-binding cassette transporter ABCA1 and ABCG1 (ABCA1\/G1)-mediated macrophage cholesterol efflux to APOB-depleted plasma was decreased in patients with STEMI, and the latter was further impaired in those who died during follow-up. Moreover, the circulating concentrations of TMAO, \u03b3BB, and TML were higher in the deceased STEMI patients when compared with the STEMI survivors or UA patients. However, after statistical adjustment, only ABCA1\/G1-mediated macrophage cholesterol efflux remained significantly associated with mortality. Furthermore, neither the TMAO, \u03b3BB, nor TML levels altered the HDL-mediated macrophage cholesterol efflux in vitro. We conclude that impaired ABCA1\/G1-mediated macrophage cholesterol efflux is independently associated with mortality at follow-up in STEMI patients.<\/jats:p>","DOI":"10.3390\/biomedicines9101336","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T21:40:30Z","timestamp":1632778830000},"page":"1336","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Capacity of APOB-Depleted Plasma in Inducing ATP-Binding Cassette A1\/G1-Mediated Macrophage Cholesterol Efflux\u2014But Not Gut Microbial-Derived Metabolites\u2014Is Independently Associated with Mortality in Patients with ST-Segment Elevation Myocardial Infarction"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0278-5337","authenticated-orcid":false,"given":"Marina","family":"Canyelles","sequence":"first","affiliation":[{"name":"Institut de Recerca de l\u2019Hospital Santa Creu i Sant Pau, Institut d\u2019Investigacions Biom\u00e8diques, IIB Sant Pau, 08041 Barcelona, Spain"},{"name":"Department of Clinical Biochemistry, Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, 08041 Barcelona, Spain"},{"name":"CIBER de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM), 28029 Madrid, Spain"},{"name":"Department de Bioqu\u00edmica i Biologia Molecular, Universitat Aut\u00f2noma de Barcelona, 08041 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6682-0226","authenticated-orcid":false,"given":"\u00c1lvaro","family":"Garc\u00eda-Osuna","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, 08041 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Junza","sequence":"additional","affiliation":[{"name":"CIBER de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM), 28029 Madrid, Spain"},{"name":"Metabolomics Platform, Department of Electronic Engineering, Universitat Rovira i Virgili, 43204 Reus, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3695-7157","authenticated-orcid":false,"given":"Oscar","family":"Yanes","sequence":"additional","affiliation":[{"name":"CIBER de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM), 28029 Madrid, Spain"},{"name":"Metabolomics Platform, Department of Electronic Engineering, Universitat Rovira i Virgili, 43204 Reus, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00faria","family":"Puig","sequence":"additional","affiliation":[{"name":"Institut de Recerca de l\u2019Hospital Santa Creu i Sant Pau, Institut d\u2019Investigacions Biom\u00e8diques, IIB Sant Pau, 08041 Barcelona, Spain"},{"name":"Department de Bioqu\u00edmica i Biologia Molecular, Universitat Aut\u00f2noma de Barcelona, 08041 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4896-5832","authenticated-orcid":false,"given":"Jordi","family":"Ord\u00f3\u00f1ez-Llanos","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, 08041 Barcelona, Spain"},{"name":"Fundaci\u00f3 per la Bioqu\u00edmica i la Patologia Molecular, 08041 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Sionis","sequence":"additional","affiliation":[{"name":"Servei de Cardiolog\u00eda, Hospital Santa Creu i Sant Pau, 08041 Barcelona, Spain"},{"name":"CIBER de Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3176-6191","authenticated-orcid":false,"given":"Jordi","family":"Sans-Rosell\u00f3","sequence":"additional","affiliation":[{"name":"Servei de Cardiolog\u00eda, Hospital Santa Creu i Sant Pau, 08041 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4164-274X","authenticated-orcid":false,"given":"Aitor","family":"Alqu\u00e9zar-Arb\u00e9","sequence":"additional","affiliation":[{"name":"Servei d\u2019Urg\u00e8ncies, Hospital Santa Creu i Sant Pau, 08041 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Santos","sequence":"additional","affiliation":[{"name":"Institut de Recerca de l\u2019Hospital Santa Creu i Sant Pau, Institut d\u2019Investigacions Biom\u00e8diques, IIB Sant Pau, 08041 Barcelona, Spain"},{"name":"CIBER de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM), 28029 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0587-8045","authenticated-orcid":false,"given":"Noemi","family":"Rotllan","sequence":"additional","affiliation":[{"name":"Institut de Recerca de l\u2019Hospital Santa Creu i Sant Pau, Institut d\u2019Investigacions Biom\u00e8diques, IIB Sant Pau, 08041 Barcelona, Spain"},{"name":"CIBER de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM), 28029 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6531-2246","authenticated-orcid":false,"given":"Josep","family":"Julve","sequence":"additional","affiliation":[{"name":"Institut de Recerca de l\u2019Hospital Santa Creu i Sant Pau, Institut d\u2019Investigacions Biom\u00e8diques, IIB Sant Pau, 08041 Barcelona, Spain"},{"name":"CIBER de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM), 28029 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0301-9984","authenticated-orcid":false,"given":"Mireia","family":"Tondo","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, 08041 Barcelona, Spain"},{"name":"CIBER de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM), 28029 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9021-2485","authenticated-orcid":false,"given":"Joan Carles","family":"Escol\u00e0-Gil","sequence":"additional","affiliation":[{"name":"Institut de Recerca de l\u2019Hospital Santa Creu i Sant Pau, Institut d\u2019Investigacions Biom\u00e8diques, IIB Sant Pau, 08041 Barcelona, Spain"},{"name":"CIBER de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM), 28029 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7380-5385","authenticated-orcid":false,"given":"Francisco","family":"Blanco-Vaca","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, 08041 Barcelona, Spain"},{"name":"CIBER de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM), 28029 Madrid, Spain"},{"name":"Department de Bioqu\u00edmica i Biologia Molecular, Universitat Aut\u00f2noma de Barcelona, 08041 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1161\/CIRCULATIONAHA.120.044221","article-title":"HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research","volume":"143","author":"Rohatgi","year":"2021","journal-title":"Circulation"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1161\/ATVBAHA.113.301373","article-title":"Paradoxical Association of Enhanced Cholesterol Efflux with Increased Incident Cardiovascular Risks","volume":"33","author":"Li","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events","volume":"371","author":"Rohatgi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S2213-8587(15)00126-6","article-title":"Association of HDL cholesterol efflux capacity with incident coronary heart disease events: A prospective case-control study","volume":"3","author":"Saleheen","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_6","first-page":"1870","article-title":"HDL cholesterol efflux capacity and cardiovascular events","volume":"372","author":"Ritsch","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.atherosclerosis.2015.10.111","article-title":"Cholesterol efflux capacity is an independent predictor of all-cause and cardiovascular mortality in patients with coronary artery disease: A prospective cohort study","volume":"249","author":"Liu","year":"2016","journal-title":"Atherosclerosis"},{"doi-asserted-by":"crossref","unstructured":"Ritsch, A., Duerr, A., Kahler, P., Hunjadi, M., Stojakovic, T., Silbernagel, G., Scharnagl, H., Kleber, M.E., and M\u00e4rz, W. (2020). Cholesterol Efflux Capacity and Cardiovascular Disease: The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study. Biomedicines, 8.","key":"ref_8","DOI":"10.3390\/biomedicines8110524"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1016\/j.jacc.2018.09.080","article-title":"Association of Serum Cholesterol Efflux Capacity with Mortality in Patients with ST-Segment Elevation Myocardial Infarction","volume":"72","author":"Guerin","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_10","first-page":"814","article-title":"Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: A prognostic marker for incident cardiovascular events beyond traditional risk factors","volume":"38","author":"Li","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1093\/eurheartj\/ehz259","article-title":"Trimethyllysine, a trimethylamine N-oxide precursor, provides near- and long-term prognostic value in patients presenting with acute coronary syndromes","volume":"40","author":"Li","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.jacc.2014.02.617","article-title":"Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: Refining the gut hypothesis","volume":"64","author":"Tang","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/heartjnl-2015-308826","article-title":"TrimethylamineN-oxide and prognosis in acute heart failure","volume":"102","author":"Suzuki","year":"2016","journal-title":"Heart"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/CIRCRESAHA.116.305360","article-title":"Gut Microbiota-Dependent Trimethylamine N -Oxide (TMAO) Pathway Contributes to Both Development of Renal Insufficiency and Mortality Risk in Chronic Kidney Disease","volume":"116","author":"Tang","year":"2015","journal-title":"Circ. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1373\/clinchem.2016.264853","article-title":"Trimethylamine N-oxide and Risk Stratification after Acute Myocardial Infarction","volume":"63","author":"Suzuki","year":"2017","journal-title":"Clin. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e015331","DOI":"10.1161\/JAHA.119.015331","article-title":"Gut Microbiota-Dependent Trimethylamine N-oxide and Cardiovascular Outcomes in Patients with Prior Myocardial Infarction: A Nested Case Control Study from the PEGASUS-TIMI 54 Trial","volume":"9","author":"Gencer","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e007281","DOI":"10.1161\/CIRCINTERVENTIONS.118.007281","article-title":"Plasma Trimethylamine N-Oxide as a Novel Biomarker for Plaque Rupture in Patients With ST-Segment\u2013Elevation Myocardial Infarction","volume":"12","author":"Tan","year":"2019","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.atherosclerosis.2016.01.033","article-title":"The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis","volume":"247","author":"Skagen","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/joim.13067","article-title":"Circulating trimethyllysine and risk of acute myocardial infarction in patients with suspected stable coronary heart disease","volume":"288","author":"Olset","year":"2020","journal-title":"J. Intern. Med."},{"doi-asserted-by":"crossref","unstructured":"Canyelles, M., Tondo, M., Ced\u00f3, L., Farr\u00e0s, M., Escol\u00e0-Gil, J.C., and Blanco-Vaca, F. (2018). Trimethylamine N-Oxide: A Link among Diet, Gut Microbiota, Gene Regulation of Liver and Intestine Cholesterol Homeostasis and HDL Function. Int. J. Mol. Sci., 19.","key":"ref_20","DOI":"10.3390\/ijms19103228"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut Flora Metabolism of Phosphatidylcholine Promotes Cardiovascular Disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth","year":"2013","journal-title":"Nat. Med."},{"key":"ref_23","first-page":"94","article-title":"Expression levels of heat shock protein 60 and glucose-regulated protein 78 in response to trimethylamine-N-oxide treatment in murine macrophage J774A.1 cell line","volume":"61","author":"Mohammadi","year":"2015","journal-title":"Cell. Mol. Boil."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.atherosclerosis.2015.10.108","article-title":"L-carnitine intake and high trimethylamine N-oxide plasma levels correlate with low aortic lesions in apoE(-\/-) transgenic mice expressing CETP","volume":"244","author":"Collins","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/CIR.0b013e31826e1058","article-title":"Third Universal Definition of Myocardial Infarction","volume":"126","author":"Thygesen","year":"2012","journal-title":"Circulation"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"33","author":"Steg","year":"2012","journal-title":"Eur. Heart J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e004425","DOI":"10.1136\/bmjopen-2013-004425","article-title":"Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score","volume":"4","author":"Fitzgerald","year":"2014","journal-title":"BMJ Open"},{"doi-asserted-by":"crossref","unstructured":"Ced\u00f3, L., Fern\u00e1ndez-Castillejo, S., Rubi\u00f3, L., Metso, J., Santos, D., Mu\u00f1oz-Aguayo, D., Rivas-Urbina, A., Tondo, M., M\u00e9ndez-Lara, K.A., and Farr\u00e0s, M. (2020). Phenol-Enriched Virgin Olive Oil Promotes Macrophage-Specific Reverse Cholesterol Transport In Vivo. Biomedicines, 8.","key":"ref_28","DOI":"10.3390\/biomedicines8080266"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.atherosclerosis.2020.04.015","article-title":"High density lipoprotein functionality and cardiovascular events and mortality: A systematic review and meta-analysis","volume":"302","author":"Schroder","year":"2020","journal-title":"Atherosclerosis"},{"key":"ref_30","first-page":"566","article-title":"HDL functionality in reverse cholesterol transport\u2014Challenges in translating data emerging from mouse models to human disease","volume":"1861","author":"Kovanen","year":"2016","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Cell Biol. Lipids"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1172\/jci.insight.99096","article-title":"Untargeted metabolomics identifies trimethyllysine, a TMAO-producing nutrient precursor, as a predictor of incident cardiovascular disease risk","volume":"3","author":"Li","year":"2018","journal-title":"JCI Insight"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.atherosclerosis.2015.10.091","article-title":"Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control","volume":"243","author":"Mueller","year":"2015","journal-title":"Atherosclerosis"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1093\/eurheartj\/ehx342","article-title":"Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: A systematic review and dose-response meta-analysis","volume":"38","author":"Schiattarella","year":"2017","journal-title":"Eur. Heart J."},{"doi-asserted-by":"crossref","unstructured":"Yao, M.-E., Liao, P.-D., Zhao, X.-J., and Wang, L. (2020). Trimethylamine-N-oxide has prognostic value in coronary heart disease: A meta-analysis and dose-response analysis. BMC Cardiovasc. Disord., 20.","key":"ref_34","DOI":"10.1186\/s12872-019-01310-5"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur. Heart J."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/10\/1336\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:05:57Z","timestamp":1760166357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/10\/1336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,27]]},"references-count":35,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["biomedicines9101336"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines9101336","relation":{},"ISSN":["2227-9059"],"issn-type":[{"type":"electronic","value":"2227-9059"}],"subject":[],"published":{"date-parts":[[2021,9,27]]}}}